Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138001000087118 | FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22421000087110 | TBE FSME-IMMUN BAG | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22441000087118 | FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 74081000087110 | ETT FSME-IMMUN BAG | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | est un(e) (attribut) | TBE tick-borne encephalitis unspecified | true | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | a pour principe actif (attribut) | Inactivated whole Tick-borne encephalitis virus Neudorfl strain antigen | true | Inferred relationship | Some | 1 | |
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | Has supplier | Baxter AG (supplier) | true | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | est un(e) (attribut) | Tick-borne encephalitis vaccine (product) | false | Inferred relationship | Some | ||
| FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) | a pour principe actif (attribut) | Tick-borne encephalitis vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Historical name codes for vaccines reference set (foundation metadata concept)
FHIR